Skip to main navigation Skip to content Skip to footer
Featured Story

The Future of Medicine Rises in University City: University of Pennsylvania Opens New Multi-Disciplinary Research Labs in One uCity Square

September 14, 2023

All News

November 17, 2023

Lab Notes: Vittoria Biotherapeutics raises $15M

Philadelphia Business Journal
November 9, 2023

Century Therapeutics appoints industry veteran as new CEO

Philadelphia Business Journal
October 23, 2023

CRADL® (Charles River Accelerator and Development Lab) opens at uCity Square

Charles River Laboratories
October 4, 2023

uCity Square Beer Garden: A Vibrant Pop-Up Bar Opens in University City

Press Release
September 21, 2023

As One uCity Square nears capacity, developer plots surrounding innovation campus and hotel addition

Philadelphia Business Journal
September 18, 2023

One uCity Square is officially open, housing life science companies and research labs

Technically Media
September 14, 2023

Wexford Science & Technology and Partners Cut Ribbon on One uCity Square

uCity Square Press Release
A tan building with gray steps leading up to an entrance bordered by white walls. The words Monell Chemical Senses Center is on a sign across the front of the building. A golden statue of a face stands to one side with a plague underneath.
July 21, 2023

Lab Notes: Monell joins public-private initiative to improve pediatric HIV drugs

Philadelphia Business Journal
June 14, 2023

One uCity Square now 90% leased after adding a pair of new life sciences tenants

Philadelphia Business Journal
Two people, male and female, both wearing lab coats, work on some lab equipment.
June 5, 2023

Exponent’s Philadelphia Office Moves to a New Smart Facility

uCity Square
Integral Molecular cuts the ribbon on its new 32,000 SF headquarters and research facility with Senator Vincent Hughes, Mayor Jim Kenney, and development partners Wexford & Science Center
April 21, 2023

Integral Molecular Opens New Research Center at uCity Square

Integral Molecular
Century Therapeutics shares soar on potential multibillion-dollar deal with Bristol Myers Squibb
January 10, 2023

Carisma Therapeutics to get $80M in cash and investment through new deal with Moderna

Philadelphia Business Journal

Subscribe to our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.